These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
12. Urological complications following use of recombinant human bone morphogenetic protein-2 in anterior lumbar interbody fusion: presented at the 2012 Joint Spine Section Meeting: clinical article. Lubelski D, Abdullah KG, Nowacki AS, Alvin MD, Steinmetz MP, Chakka S, Li Y, Gajewski N, Benzel EC, Mroz TE. J Neurosurg Spine; 2013 Feb; 18(2):126-31. PubMed ID: 23231356 [Abstract] [Full Text] [Related]
13. Comparison of TLIF with rhBMP-2 versus no TLIF and higher posterolateral rhBMP-2 dose at L5-S1 for long fusions to the sacrum with sacropelvic fixation in patients with primary adult deformity. Rahman RK, Buchowski JM, Stephens B, Dorward IG, Koester LA, Bridwell KH. Spine (Phila Pa 1976); 2013 Dec 15; 38(26):2264-71. PubMed ID: 24108280 [Abstract] [Full Text] [Related]
14. Quantitative assessment of retrograde ejaculation using semen analysis, comparison with a standardized qualitative questionnaire, and investigating the impact of rhBMP-2. Tepper G, Rabbani R, Yousefzadeh M, Prince D. Spine (Phila Pa 1976); 2013 May 01; 38(10):841-5. PubMed ID: 23403551 [Abstract] [Full Text] [Related]
19. Comparison of a calcium phosphate bone substitute with recombinant human bone morphogenetic protein-2: a prospective study of fusion rates, clinical outcomes and complications with 24-month follow-up. Parker RM, Malham GM. Eur Spine J; 2017 Mar 01; 26(3):754-763. PubMed ID: 28028645 [Abstract] [Full Text] [Related]